Try it
PSM · Communicable diseases: lymphatic filariasis mass drug administration
Sample itemDuring a mass drug administration round for lymphatic filariasis using diethylcarbamazine and albendazole, which of the following should be excluded from receiving the drugs?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
C. A 12-month-old infant
In the national filariasis elimination programme, the annual mass drug administration covers all eligible people in endemic districts. Children below 2 years, pregnant women and seriously ill people are excluded. Common side effects are due to dying microfilariae and are mild and transient.
Option by option
A. A 6-year-old child
School-age children are a main target group and are eligible.
B. A 60-year-old woman with diabetes
Diabetes in an older adult is not an exclusion criterion.
C. A 12-month-old infant (correct)
Correct. Children below 2 years are excluded from the programme.
D. A 35-year-old man with treated hypertension
Controlled hypertension is not a contraindication to the drugs.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More PSM questions
- BiostatisticsOf 200 people who truly have a disease, a screening test is positive in 180. What is the…
- Environmental healthAfter one hour of contact time, what residual free chlorine level is generally recommend…
- EpidemiologyWhich study design is the most efficient for investigating risk factors of a rare disease?
- BiostatisticsIn hypothesis testing, a Type I error is: